Hermann Luebbert - 18 May 2023 Form 4 Insider Report for Biofrontera Inc. (BFRI)

Role
Executive Chairman, Director
Signature
/s/ Daniel Hakansson, Attorney-in-fact for Hermann Luebbert
Issuer symbol
BFRI
Transactions as of
18 May 2023
Transactions value $
$0
Form type
4
Filing time
22 May 2023, 21:01:19 UTC
Previous filing
19 Sep 2022
Next filing
22 May 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BFRI Common Stock Options Exercise +95,420 +84.2% 208,799 18 May 2023 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BFRI Restricted Stock Units Options Exercise $0 -95,420 -50% $0.000000 95,420 18 May 2023 Commom Stock 95,420 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units covert into common stock on a one-for-one basis.
F2 On May 18, 2022, the reporting person was granted 190,840 restricted stock units, vesting in two equal annual installments beginning on May 18,2023.